-
公开(公告)号：US09867857B2
公开(公告)日：2018-01-16
申请号：US14829868
申请日：2015-08-19
发明人： Siao-Jhen Cheng , Yen-Lin Chen , Hsun-Yin Hsu , Kai-Ping Chen , Chiao-Ming Liao , Yi-Jen Yech
IPC分类号： A61K35/74 , A61K36/06 , A23L33/135
CPC分类号： A61K35/74 , A23L33/135 , A23Y2220/35 , A23Y2220/37 , A23Y2220/61 , A23Y2220/65 , A23Y2300/55 , A61K36/06 , A61K2300/00
摘要： A method for inhibiting xanthine oxidase and for reducing uric acid levels using a pharmaceutical composition or a food product obtained by culturing Gluconacetobacter hansenii or Acetobacter pasteurianus in a medium. Also disclosed is a pharmaceutical composition and a food product that each include a metabolite of Gluconacetobacter hansenii or Acetobacter pasteurianus for reducing uric acid levels in a subject and methods for producing the pharmaceutical composition and the food product.
-
公开(公告)号：US20050265984A1
公开(公告)日：2005-12-01
申请号：US11094575
申请日：2005-03-31
申请人： Yuji Nonaka , Takayuki Izumo , Keiko Ilda
发明人： Yuji Nonaka , Takayuki Izumo , Keiko Ilda
CPC分类号： A61K35/747 , A23C9/1234 , A23L2/52 , A23L33/135 , A23V2002/00 , A23V2200/00 , A23V2200/30 , A23Y2220/65 , Y10S435/853 , A23V2200/304 , A23V2200/324
摘要： The invention provides a composition comprising novel lactic acid bacteria having immunoregulating activities. Specifically, the invention provides food, drinks or medicaments containing novel lactic acid bacteria separated from “Shibazuke,” one kind of traditional Kyoto pickles, and having immunoregulating activities. The lactic acid bacteria belong to Lactobacillus pentosus and have a weak assimilating activity or no assimilating activity for glycerol.
摘要翻译： 本发明提供了包含具有免疫调节活性的新型乳酸菌的组合物。 具体而言，本发明提供了含有从“Shibazuke”分离的新型乳酸菌的食品，饮料或药物，一种传统的京都酱菜，并具有免疫调节活性。 乳酸菌属于戊糖乳杆菌，对甘油具有弱的同化活性或不同化活性。
-
公开(公告)号：US09603880B2
公开(公告)日：2017-03-28
申请号：US14784064
申请日：2014-04-16
发明人： Eiji Fukushima
IPC分类号： A01N63/00 , A61K35/747 , C12R1/225 , A23L33/135 , A61K35/00
CPC分类号： A23L2/382 , A23C9/1234 , A23L33/135 , A23V2002/00 , A23Y2220/65 , A61K35/747 , A61K2035/115 , C12R1/225
摘要： A composition containing a Lactobacillus pentosus TUA4337L strain (accession number: NITE BP-1479), characterized in that the strain has proliferation ability in the small intestines and/or the large intestine, and preferably the small intestines, after having survived in the intestinal tract. Since the composition of the present invention contains lactic acid bacteria having proliferation ability in the intestinal tract, when ingested in the body, the lactic acid bacteria survive to the intestinal tract and proliferate, whereby the fat absorption can be blocked, and the weight gains can be blocked, so that the composition can be suitably used for the purposes of dieting effects.
-
4.发明申请公开(公告)号：US20100055238A1
公开(公告)日：2010-03-04
申请号：US12374246
申请日：2007-07-03
申请人： Giammaria Giuliani , Anna Benedusi , Raffaella Di Cagno , Maria De Angelis , Antonella Luisi , Marco Gobbetti
发明人： Giammaria Giuliani , Anna Benedusi , Raffaella Di Cagno , Maria De Angelis , Antonella Luisi , Marco Gobbetti
CPC分类号： A21D8/04 , A21D8/045 , A21D10/002 , A21D13/04 , A21D13/047 , A21D13/066 , A21D13/40 , A23Y2220/05 , A23Y2220/13 , A23Y2220/17 , A23Y2220/25 , A23Y2220/29 , A23Y2220/35 , A23Y2220/37 , A23Y2220/39 , A23Y2220/63 , A23Y2220/65 , A23Y2220/67 , A23Y2220/81 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/24 , C12R1/25
摘要： The present invention concerns a mixture of lactic bacteria for yeasting of gluten-free baked products. Particularly, the invention concerns the use of “natural yeast” based on selected lactic bacteria as yeasting agent for the production of gluten-free bread, with improved sensory and nutritional property, designed for celiac patients feeding.
摘要翻译： 本发明涉及用于无麸质焙烤产品的酵母的乳酸菌混合物。 特别地，本发明涉及基于选择的乳酸菌的“天然酵母”作为酵母剂用于生产无麸质面包的用途，其具有改进的感官和营养特性，其设计用于腹腔食物喂养。
-
5.发明授权公开(公告)号：US09560854B2
公开(公告)日：2017-02-07
申请号：US14622587
申请日：2015-02-13
申请人： GIULIANI S.p.A.
发明人： Giammaria Giuliani , Anna Benedusi , Raffaella Di Cagno , Maria De Angelis , Antonella Luisi , Marco Gobbetti
IPC分类号： C12N1/20 , A21D8/04 , A21D13/04 , A21D13/06 , C12R1/01 , C12R1/225 , C12R1/24 , C12R1/25 , A21D10/00
CPC分类号： A21D8/04 , A21D8/045 , A21D10/002 , A21D13/04 , A21D13/047 , A21D13/066 , A21D13/40 , A23Y2220/05 , A23Y2220/13 , A23Y2220/17 , A23Y2220/25 , A23Y2220/29 , A23Y2220/35 , A23Y2220/37 , A23Y2220/39 , A23Y2220/63 , A23Y2220/65 , A23Y2220/67 , A23Y2220/81 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/24 , C12R1/25
摘要： The present invention concerns a mixture of lactic bacteria for yeasting of gluten-free baked products. Particularly, the invention concerns the use of “natural yeast” based on selected lactic bacteria as yeasting agent for the production of gluten-free bread, with improved sensory and nutritional property, designed for celiac patients feeding.
摘要翻译： 本发明涉及用于无麸质焙烤产品的酵母的乳酸菌混合物。 特别地，本发明涉及基于选择的乳酸菌的“天然酵母”作为酵母剂用于生产无麸质面包的用途，其具有改进的感官和营养特性，其设计用于腹腔食物喂养。
-
公开(公告)号：US20160058807A1
公开(公告)日：2016-03-03
申请号：US14784064
申请日：2014-04-16
发明人： Eiji Fukushima
IPC分类号： A61K35/747
CPC分类号： A23L2/382 , A23C9/1234 , A23L33/135 , A23V2002/00 , A23Y2220/65 , A61K35/747 , A61K2035/115 , C12R1/225
摘要： A composition containing a Lactobacillus pentosus TUA4337L strain (accession number: NITE BP-1479), characterized in that the strain has proliferation ability in the small intestines and/or the large intestine, and preferably the small intestines, after having survived in the intestinal tract. Since the composition of the present invention contains lactic acid bacteria having proliferation ability in the intestinal tract, when ingested in the body, the lactic acid bacteria survive to the intestinal tract and proliferate, whereby the fat absorption can be blocked, and the weight gains can be blocked, so that the composition can be suitably used for the purposes of dieting effects.
摘要翻译： 一种含有戊糖乳酸杆菌TUA4337L菌株（登录号：NITE BP-1479）的组合物，其特征在于该菌株在肠道中存活后在小肠和/或大肠，优选小肠中具有增殖能力 。 由于本发明的组合物含有在肠道中具有增殖能力的乳酸菌，因此在体内摄入时，乳酸菌能够存活于肠道并增殖，从而能够阻止脂肪的吸收， 被阻塞，使得组合物可以适当地用于节食效果的目的。
-
7.发明申请NOVEL ACETOBACTER AND GLUCONACETOBACTER STRAINS AND THEIR METABOLITES FOR USE IN INHIBITING XANTHINE OXIDASE 有权新型ACETOBACTER和GLUCONACETOBACTER菌株及其代谢物用于抑制Xanthine氧化酶公开(公告)号：US20160051598A1
公开(公告)日：2016-02-25
申请号：US14829868
申请日：2015-08-19
发明人： Siao-Jhen Cheng , Yen-Lin Chen , Hsun-Yin Hsu , Kai-Ping Chen , Chiao-Ming Liao , Yi-Jen Yech
CPC分类号： A61K35/74 , A23L33/135 , A23Y2220/35 , A23Y2220/37 , A23Y2220/61 , A23Y2220/65 , A23Y2300/55 , A61K36/06 , A61K2300/00
摘要： A method for inhibiting xanthine oxidase and for reducing uric acid levels using a pharmaceutical composition or a food product obtained by culturing Gluconacetobacter hansenii or Acetobacter pasteurianus in a medium. Also disclosed is a pharmaceutical composition and a food product that each include a metabolite of Gluconacetobacter hansenii or Acetobacter pasteurianus for reducing uric acid levels in a subject and methods for producing the pharmaceutical composition and the food product.
摘要翻译： 使用药物组合物或通过在培养基中培养汉堡酵母或醋酸巴西醋杆菌获得的食品来抑制黄嘌呤氧化酶并降低尿酸水平的方法。 还公开了药物组合物和食品，其各自包含用于降低受试者的尿酸水平的葡萄糖醋酸葡萄糖醋杆菌或巴氏醋酸巴布酯的代谢物，以及用于制备药物组合物和食品的方法。
-
8.发明申请STRAINS OF LACTIC ACID BACTERIA AND/OR BIFIDOBACTERIA INHIBITING/REDUCING THE GROWTH OF DIFFERENT BIOTYPES OF E. COLI AND DIFFERENT BIOTYPES OF CLOSTRIDIA 审中-公开乳酸菌和/或双歧杆菌的菌株抑制/减少大肠杆菌和不同生物群落的不同生物的生长公开(公告)号：US20150017128A1
公开(公告)日：2015-01-15
申请号：US14344047
申请日：2012-09-10
申请人： Giovanni Mogna
发明人： Giovanni Mogna
IPC分类号： A61K35/74 , A61K38/47 , A23L1/30 , A61K31/198
CPC分类号： A61K35/747 , A23L33/135 , A23L33/17 , A23L33/175 , A23L33/21 , A23V2002/00 , A23Y2220/65 , A23Y2220/73 , A61K31/198 , A61K35/745 , A61K38/47 , A61K47/44 , C12N1/20 , C12Y302/01017 , Y02A50/473 , A61K2300/00
摘要： The present disclosure refers to strains of lactic bacteria and/or bifidobacteria having activity of inhibiting/reducing the growth of different biotypes of E. coli, including E. coli 0157:7 and different biotypes of clostridia, including Clostridium difficile, Listeria monocytogenes, Enterococcus sp. and Klebsiella sp. Furthermore, the present invention refers to a pharmaceutical or dietary composition or a supplement or a medical device with at least one of the said strains of bacteria, optionally in combination with acetylcysteine and/or microencapsulated gastroprotected lysozyme and/or acetylcysteine with microencapsulated gastro-protected lysozyme.
摘要翻译： 本公开涉及具有抑制/减少大肠杆菌不同生物型的生物活性的乳酸菌和/或双歧杆菌的菌株，包括大肠杆菌0157：7和梭菌的不同生物型，包括艰难梭菌，单核细胞增生利斯特氏菌，肠球菌 sp。 和克雷伯菌属 此外，本发明涉及具有所述细菌菌株中的至少一种，任选地与乙酰半胱氨酸和/或微囊化胃保护溶菌酶和/或乙酰半胱氨酸组合的药物或饮食组合物或补充剂或医疗装置，其具有微囊化的胃保护 溶菌酶
-
9.发明授权公开(公告)号：US09237753B2
公开(公告)日：2016-01-19
申请号：US12374246
申请日：2007-07-03
申请人： Giammaria Giuliani , Anna Benedusi , Raffaella Di Cagno , Maria De Angelis , Antonella Luisi , Marco Gobbetti
发明人： Giammaria Giuliani , Anna Benedusi , Raffaella Di Cagno , Maria De Angelis , Antonella Luisi , Marco Gobbetti
IPC分类号： C12N1/20 , A21D8/04 , A21D13/04 , A21D13/06 , C12R1/01 , C12R1/225 , C12R1/24 , C12R1/25 , A21D10/00
CPC分类号： A21D8/04 , A21D8/045 , A21D10/002 , A21D13/04 , A21D13/047 , A21D13/066 , A21D13/40 , A23Y2220/05 , A23Y2220/13 , A23Y2220/17 , A23Y2220/25 , A23Y2220/29 , A23Y2220/35 , A23Y2220/37 , A23Y2220/39 , A23Y2220/63 , A23Y2220/65 , A23Y2220/67 , A23Y2220/81 , C12N1/20 , C12R1/01 , C12R1/225 , C12R1/24 , C12R1/25
摘要： The present invention concerns a mixture of lactic bacteria for yeasting of gluten-free baked products. Particularly, the invention concerns the use of “natural yeast” based on selected lactic bacteria as yeasting agent for the production of gluten-free bread, with improved sensory and nutritional property, designed for celiac patients feeding.
摘要翻译： 本发明涉及用于无麸质焙烤产品的酵母的乳酸菌混合物。 特别地，本发明涉及基于选择的乳酸菌的“天然酵母”作为酵母剂用于生产无麸质面包的用途，其具有改进的感官和营养特性，其设计用于腹腔食物喂养。
-
10.发明授权Bacteriocin-producing Lactobacillus pentosus and the use thereof in food and pharmaceutical compositions 有权产生细菌素的戊糖乳杆菌及其在食品和药物组合物中的用途公开(公告)号：US09185927B2
公开(公告)日：2015-11-17
申请号：US13322795
申请日：2010-05-27
申请人： Giovanni Mogna , Gian Paolo Strozzi , Luca Mogna
发明人： Giovanni Mogna , Gian Paolo Strozzi , Luca Mogna
IPC分类号： C12N1/20 , A23L1/30 , A61K35/747 , C12R1/225
CPC分类号： A23L1/3014 , A23L33/135 , A23Y2220/65 , A61K35/747 , C12R1/225 , Y02A50/473
摘要： The present invention relates to a selected strain of Lactobacillus pentosus for use as a medication for the preventive or curative treatment of infections due to Gram-negative bacteria, preferably enterococci, coliforms and E. coli.
摘要翻译： 本发明涉及一种选择的戊酸乳杆菌菌株，用作用于预防或治疗由革兰氏阴性细菌，优选肠球菌，大肠杆菌和大肠杆菌引起的感染的药物。
-
-
-
-
-
-
-
-
-
搜索结果
16 条记录 (耗时 0.01 秒)
